Security key
83558L303
- Security type / class
- Equity / COM
- Total 13F shares
- 84,902
- Total 13F value
- $241,989
- Share change
- +51,845
- SEC-reported price per share
- $2.84
- Number of holders
- 13
- Value change
- +$156,743
- Number of buys
- 6
- Number of sells
- 4
Report period
Q2 2025
Institutions
13
Top holders
10
SNOA full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q3 2025
Sonoma Pharmaceuticals, Inc. SEC filings
Sonoma Pharmaceuticals, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 83558L303
Recent filing periods:
Ownership snapshot
Top reported holders of SNOA - Sonoma Pharmaceuticals, Inc. - COM (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
GEODE CAPITAL MANAGEMENT,...
Disclosed value leader
GEODE CAPITAL MANAGEMENT,...
Comparable rows
0/14
Latest evidence
19 Jun 2025
13F
3/4/5
Highest disclosed value: $36,802
14 rows are not safely comparable across share classes.
Showing 1-6 of 14 holder rows.
Quick read
GEODE CAPITAL MANAGEMENT, LLC has the largest disclosed position value at $36.8K.
0 of 14 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens GEODE CAPITAL MANAGEMENT, LLC's linked filing trail.
Disclosed position value
Top 5
GEODE CAPITAL MANAGEMENT, LLC
$36.8K
HRT FINANCIAL LP
$25K
UBS Group AG
$4.1K
Tower Research Capital LLC (TRC)
$3.2K
CITIGROUP INC
$1.8K
Value bars compare disclosed positions; verify each figure against the linked filing evidence.
Detailed SEC evidence table Showing 1-6 of 14 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| GEODE CAPITAL MANAGEMENT, LLC |
13F
Company
|
—
denominator unverified
|
$36,802
16,805 shares
|
— | 31 Mar 2025 |
| HRT FINANCIAL LP |
13F
Company
|
—
denominator unverified
|
$25,000
11,843 shares
|
— | 31 Mar 2025 |
| UBS Group AG |
13F
Company
|
—
denominator unverified
|
$4,056
1,852 shares
|
— | 31 Mar 2025 |
| Tower Research Capital LLC (TRC) |
13F
Company
|
—
denominator unverified
|
$3,169
1,447 shares
|
— | 31 Mar 2025 |
| CITIGROUP INC |
13F
Company
|
—
denominator unverified
|
$1,776
811 shares
|
— | 31 Mar 2025 |
| JPMORGAN CHASE & CO |
13F
Company
|
—
denominator unverified
|
$302
138 shares
|
— | 31 Mar 2025 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q2 2025
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
13
Shares
84,902
Rows available
13
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q2 2025 vs Q2 2026 Across Filers
Q2 2026 holders
14
Q2 2025 holders
13
Holder diff
-1
| Investor | Q2 2026 Shares | Q2 2025 Shares | Share Diff | Share Chg % | Q2 2026 value | Q2 2025 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend